INTRODUCTION: It is recognised that the desired therapeutic effect of most Anti-epileptic Drugs (AEDs) is achieved within a specific concentration range, with lower levels giving an unsatisfactory response and higher levels possibly giving undesirable side-effects. Large inter-individual differences in drug disposition occur, and many refractory patients require treatment with several AEDs. Thus, monitoring serum/plasma concentrations of AEDs has proved to be an extremely useful means of assisting in the individualisation of treatment. A large number of AEDs are available and it is necessary to quantitatively determine each compound that a patient is prescribed. Assay methods include a range of gas- and liquid- chromatographic procedures, and specific immunoassays, although the latter are not available for all AEDs. This work describes an Ultra Performance Liquid Chromatography – tandem mass spectrometry (UPLC/MS/MS) method capable of analysing a panel of AEDs, and, where appropriate, the active metabolite, simultaneously in a single procedure. METHODOLOGY: Sample preparation consisted of a simple protein precipitation using aqueous zinc sulphate and methanol. The resulting supernatant was diluted with mobile phase to give a response in the linear range of the analyte. A reversed phase UPLC method, using a Waters ACQUITY UPLC™ BEH C18 2.1x50mm 1.7µm column was developed to meet the demands of the clinical laboratory for speed of analysis, chromatographic resolution and sensitivity. The mobile phase consisted of :- Solvent A: aqueous ammonium acetate and solvent B: methanolic ammonium acetate; A five-minute gradient elution from 2-75% organic phase, produced an effective separation. Detection was undertaken using a Waters Quattro Premier XE™ tandem quadrupole mass spectrometer operating in Multiple Reaction Monitoring (MRM) mode with fast (20ms) positive and negative ion mode switching and short (20ms) dwell times, commensurate with the UPLC peak widths. RESULTS: The assay for Lamotrigine was linear over the analytical range 2.9 -15.3 mg/L, with a correlation coefficient (r 2 ) of 0.995, and a precision %RSD = 4.4% at the lower concentration (n=6). The assay for Primidone was linear over the analytical range 4.3-30.0mg/L with a r 2